Ann: Change in substantial holding, page-26

Hi all,

I am a new investor here nice to meet you all.
Well I entered into the market with 700,000 shares with this Equity after some research and it was a no brainer for me..

I apologise in advance to any members/investors on here who may be negative on this stock, and who may have already discussed this, but this is just the most fundamentally attractive equity have seen in a while.

So they have;

• FDA approved product,
• Distribution pipeline and product with estimations of USD $20 million per annum revenue. ( $27.49 milion AUD )
• $34 million cash at bank
• Nil Debt

And a "market cap" of only 37.3 million.

with 396 million shares outstanding, has anyone worked out an approximation of the EPS and the equity value?

$0.095 cents in laughable....
Bollinger bands are going to squeeze here and price will push out at these levels, IMO this should be valued comfortably at $0.18 cents a share - $0.22.

Cannot see a CR needed till at least 2022 given the cash burn rate.
Also looks as though they have a lot of carried losses on the balance sheet to dribble over and pay no tax over the coming years when this cash comes in. Going off this $0.09 cents, bloody hell. I will accumulate heavily here for sure.


GLTAH glad to be on board